Lithuania vs Poland: HICP - Tea, mate and other plant-derived products for infusion (ND)
Lithuania
1.89
in 2026
Poland
1.72
in 2026
Lithuania rank
3rd
Poland rank
5th
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Lithuania
- Poland
How they compare
Lithuania currently reports 1.89 against 1.72 in Poland, a difference of 0.17.
That makes Lithuania's figure about 1.1 times Poland's.
The two have swapped places 7 times across 31 shared years of data; in 1996 it was Poland ahead.
Lithuania ranks 3rd and Poland ranks 5th of 27 countries.
Across the 4 decades both report, Lithuania averaged higher in 3 and Poland in 1.
Head to head by decade
| Decade | Lithuania | Poland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.8 | 3.55 | 1.75 | Poland |
| 2000s | 2.63 | 2.62 | 0.008 | Lithuania |
| 2010s | 2.15 | 1.98 | 0.168 | Lithuania |
| 2020s | 2.03 | 1.44 | 0.5886 | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Lithuania or Poland?
- Lithuania, at 1.89 against 1.72 in Poland as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Lithuania and Poland?
- 0.17, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Poland?
- 31 years are reported by both, from 1996 to 2026.
- How do Lithuania and Poland rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Lithuania ranks 3rd and Poland ranks 5th of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.